| Year |
Citation |
Score |
| 2021 |
Pierini S, Mishra A, Perales-Linares R, Uribe-Herranz M, Beghi S, Giglio A, Pustylnikov S, Costabile F, Rafail S, Amici A, Facciponte JG, Koumenis C, Facciabene A. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression. Journal For Immunotherapy of Cancer. 9. PMID 33563772 DOI: 10.1136/jitc-2020-001636 |
0.373 |
|
| 2018 |
De Sanctis F, Ugel S, Facciponte J, Facciabene A. The dark side of tumor-associated endothelial cells. Seminars in Immunology. PMID 29490888 DOI: 10.1016/J.Smim.2018.02.002 |
0.389 |
|
| 2017 |
Facciabene A, De Sanctis F, Pierini S, Reis ES, Balint K, Facciponte J, Rueter J, Kagabu M, Magotti P, Lanitis E, DeAngelis RA, Buckanovich RJ, Song WC, Lambris JD, Coukos G. Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy. Oncoimmunology. 6: e1326442. PMID 28932632 DOI: 10.1080/2162402X.2017.1326442 |
0.338 |
|
| 2015 |
Pierini S, Fang C, Rafail S, Facciponte JG, Huang J, De Sanctis F, Morgan MA, Uribe-Herranz M, Tanyi JL, Facciabene A. A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 26378078 DOI: 10.4049/Jimmunol.1500281 |
0.448 |
|
| 2015 |
Ugel S, Facciponte JG, De Sanctis F, Facciabene A. Targeting tumor vasculature: expanding the potential of DNA cancer vaccines. Cancer Immunology, Immunotherapy : Cii. 64: 1339-48. PMID 26267042 DOI: 10.1007/S00262-015-1747-8 |
0.443 |
|
| 2014 |
Facciponte JG, Ugel S, De Sanctis F, Li C, Wang L, Nair G, Sehgal S, Raj A, Matthaiou E, Coukos G, Facciabene A. Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature. The Journal of Clinical Investigation. 124: 1497-511. PMID 24642465 DOI: 10.1172/Jci67382 |
0.49 |
|
| 2010 |
Wang XY, Sun X, Chen X, Facciponte J, Repasky EA, Kane J, Subjeck JR. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen. Journal of Immunology (Baltimore, Md. : 1950). 184: 6309-19. PMID 20439916 DOI: 10.4049/Jimmunol.0903891 |
0.698 |
|
| 2010 |
Facciabene A, Facciponte J, Coukos G. Abstract LB-197: Tumor vasculature associated marker as a target for recombinant DNA based vaccines Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-197 |
0.374 |
|
| 2007 |
Facciponte JG, Wang XY, Subjeck JR. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. European Journal of Immunology. 37: 2268-79. PMID 17615582 DOI: 10.1002/Eji.200737127 |
0.697 |
|
| 2007 |
Wang XY, Facciponte J, Chen X, Subjeck JR, Repasky EA. Scavenger receptor-A negatively regulates antitumor immunity. Cancer Research. 67: 4996-5002. PMID 17510431 DOI: 10.1158/0008-5472.Can-06-3138 |
0.733 |
|
| 2006 |
Wang XY, Facciponte JG, Subjeck JR. Molecular chaperones and cancer immunotherapy. Handbook of Experimental Pharmacology. 305-29. PMID 16610365 DOI: 10.1007/3-540-29717-0-13 |
0.699 |
|
| 2006 |
Manjili MH, Park JE, Facciponte JG, Wang XY, Subjeck JR. Immunoadjuvant chaperone, GRP170, induces 'danger signals' upon interaction with dendritic cells. Immunology and Cell Biology. 84: 203-8. PMID 16519738 DOI: 10.1111/J.1440-1711.2006.01418.X |
0.679 |
|
| 2006 |
Park JE, Facciponte J, Chen X, MacDonald I, Repasky EA, Manjili MH, Wang XY, Subjeck JR. Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity. Cancer Research. 66: 1161-8. PMID 16424054 DOI: 10.1158/0008-5472.Can-05-2609 |
0.718 |
|
| 2006 |
Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y, Kim H, Manjili MH, Easton DP, Subjeck JR. Heat shock proteins HSP70 and GP96: structural insights. Cancer Immunology, Immunotherapy : Cii. 55: 339-46. PMID 16032399 DOI: 10.1007/S00262-005-0020-Y |
0.726 |
|
| 2005 |
Manjili MH, Park J, Facciponte JG, Subjeck JR. HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology. 210: 295-303. PMID 16164037 DOI: 10.1016/J.Imbio.2005.04.002 |
0.715 |
|
| 2005 |
Facciponte JG, MacDonald IJ, Wang XY, Kim H, Manjili MH, Subjeck JR. Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunological Investigations. 34: 325-42. PMID 16136784 DOI: 10.1081/Imm-200064505 |
0.743 |
|
| 2002 |
Manjili MH, Wang XY, Park J, Facciponte JG, Repasky EA, Subjeck JR. Immunotherapy of cancer using heat shock proteins. Frontiers in Bioscience : a Journal and Virtual Library. 7: d43-52. PMID 11779704 DOI: 10.2741/Manjili |
0.724 |
|
| Show low-probability matches. |